Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 5/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | CD44 | P16070 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MYC | P01106 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31038153 | 1.00 | PLK1 (0.50) | PLK1GAAHPGDKDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL31400038 | 0.98 | PLK1 (0.49) | PLK1GAAHPGDKDM4EALDH1A1 | |
| SCHEMBL7322497 | 0.85 | HDAC8 (0.47) | GAAHPGDKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL5252014 | 0.82 | PLK1 (0.52) | PLK1GAAHPGDKDM4EALDH1A1 | |
| SCHEMBL31301322 | 0.81 | MEN1 (0.51) | HPGDKDM4EALDH1A1SMN1; SMN2POLB | |
| SCHEMBL28023692 | 0.81 | PTGS2 (0.46) | HPGDKDM4EALDH1A1SMN1; SMN2CD44 | |
| SCHEMBL11745378 | 0.81 | POLB (0.65) | HPGDKDM4EALDH1A1SMN1; SMN2POLB | |
| SCHEMBL28089985 | 0.81 | PLK1 (0.50) | PLK1GAAHPGDKDM4EALDH1A1 | |
| SCHEMBL465699 | 0.81 | G6PD (0.55) | PLK1GAAHPGDKDM4EALDH1A1 | |
| SCHEMBL12818997 | 0.80 | MAPT (0.49) | HPGDKDM4EALDH1A1SMN1; SMN2CD44 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676908-A1 | PHOTOCHEMICAL SYSTEMS AND METHODS FOR PREPARING CYANOBENZAMIDES | FMC Corporation (US) | 2026-01-14 | — | — | EP | claimed |
| CN-120058546-A | 2-Amino-5-chloro-N, 3-dimethylbenzamide production process | 九江善水科技股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-120037937-A | Catalyst for preparing 2-amino-N, 3-dimethylbenzamide by continuous hydrogenation and preparation method and application thereof | 湖南长炼新材料科技股份公司 | 2025-05-27 | — | — | CN | claimed |
| CN-119874556-A | Synthesis method of 2-amino-N, 3-dimethylbenzamide | 北京弗莱明科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| WO-2024186513-A1 | PHOTOCHEMICAL SYSTEMS AND METHODS FOR PREPARING CYANOBENZAMIDES | FMC CORPORATION (US) | 2024-09-12 | — | — | WO | claimed |
| CN-118439967-A | Preparation method of 2-amino-5-chloro-N, 3-dimethylbenzamide | 宁夏贝利特生物科技有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-115197085-B | Preparation method of 2-amino-5-chloro-N, 3-dimethylbenzamide | 九江善水科技股份有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-116983927-B | System and method for continuously producing chlorantraniliprole | 天津凯莱英医药科技发展有限公司 | 2024-01-19 | — | — | CN | claimed |
| CN-116983927-A | System and method for continuously producing chlorantraniliprole | 天津凯莱英医药科技发展有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-115197085-A | Preparation method of 2-amino-5-chloro-N, 3-dimethylbenzamide | 九江善水科技股份有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-113480518-A | Method for synthesizing chlorantraniliprole | 江西汇和化工有限公司 | 2021-10-08 | — | — | CN | claimed |
| WO-2021033172-A1 | PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE | EUROFINS ADVINUS LIMITED (IN) | 2021-02-25 | — | — | WO | claimed |
| CN-101492387-B | Preparation for 2-amino-5-chlorine-N,3-dimethyl benzamide | UNIV ZHEJIANG | 2012-07-25 | — | — | CN | claimed |
| CN-122102936-A | Preparation method of 2-amino-5-chloro-N, 3-dimethylbenzamide | — | 2026-05-29 | — | — | CN | disclosed |
| CN-224236783-U | Hydrogenation reaction device for 2-nitro-N, 3-dimethylbenzamide | 内蒙古鲲鹏新材料有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12590070-B2 | Adamantane derivatives as inhibitors of focal adhesion kinase | SAMJIN PHARMACEUTICAL CO., LTD. (KR) | 2026-03-31 | — | — | US | disclosed |
| EP-1828164-A1 | METHOD FOR PREPARING N-PHENYLPYRAZOLE-1-CARBOXAMIDES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-09-05 | — | — | EP | disclosed |
| EP-1757594-A1 | QUINAZOLINE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-02-28 | — | — | EP | disclosed |
| WO-2006062978-A1 | METHOD FOR PREPARING N-PHENYLPYRAZOLE-1-CARBOXAMIDES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-06-15 | — | — | WO | disclosed |
| US-5726319-A | Biphenyl substituted dipeptide analogs promote release of growth hormone | MERCK & CO., INC. (US) | 1998-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590070-B2 | Adamantane derivatives as inhibitors of focal adhesion kinase | PTK2, CTTN, ADGRF1 | PLK1 700/4885GAA 4319/4885HPGD 3884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.